The benzene hematotoxic and reactive metabolite 1,4-benzoquinone impairs the activity of the histone methyltransferase SETD2 and causes aberrant H3K36 trimethylation (H3K36me3)

246

[1]  C. Chomienne,et al.  Human CREBBP acetyltransferase is impaired by etoposide quinone, an oxidative and leukemogenic metabolite of the anticancer drug etoposide through modification of redox-sensitive zinc-finger cysteine residues. , 2020, Free radical biology & medicine.

[2]  C. North,et al.  Modes of Action Considerations in Threshold Expectations for Health Effects of Benzene. , 2020, Toxicology letters.

[3]  J. Workman,et al.  Regulation of SETD2 stability is important for the fidelity of H3K36me3 deposition , 2020, Epigenetics & chromatin.

[4]  L. Winn,et al.  Benzene and its effects on cell signaling pathways related to hematopoiesis and leukemia , 2020, Journal of applied toxicology : JAT.

[5]  Z. Herceg,et al.  The Promises and Challenges of Toxico-Epigenomics: Environmental Chemicals and Their Impacts on the Epigenome , 2020, Environmental health perspectives.

[6]  P. Hägglund,et al.  Modification of Cys residues in human thioredoxin-1 by p-benzoquinone causes inhibition of its catalytic activity and activation of the ASK1/p38-MAPK signalling pathway , 2019, Redox biology.

[7]  O. Gozani,et al.  Histone lysine methyltransferases in biology and disease , 2019, Nature Structural & Molecular Biology.

[8]  L. Winn,et al.  DNA Damage and Perturbed Topoisomerase IIα as a Target of 1,4-Benzoquinone Toxicity in Murine Fetal Liver Cells. , 2019, Toxicological sciences : an official journal of the Society of Toxicology.

[9]  Elias S. J. Arnér,et al.  Inhibition and crosslinking of the selenoprotein thioredoxin reductase-1 by p-benzoquinone , 2019, Redox biology.

[10]  Ximing Xu,et al.  Benzoquinone, a leukemogenic metabolite of benzene, catalytically inhibits the protein tyrosine phosphatase PTPN2 and alters STAT1 signaling , 2019, The Journal of Biological Chemistry.

[11]  Y. Hayashi,et al.  SETD2 mutations confer chemoresistance in acute myeloid leukemia partly through altered cell cycle checkpoints , 2019, Leukemia.

[12]  M. Davies,et al.  Kinetics and biological consequences of quinone-induced protein adduction , 2018, Free Radical Biology & Medicine.

[13]  Weiguo Zou,et al.  H3K36 trimethylation mediated by SETD2 regulates the fate of bone marrow mesenchymal stem cells , 2018, PLoS biology.

[14]  Z. Yi,et al.  Benzene metabolite 1,2,4-benzenetriol changes DNA methylation and histone acetylation of erythroid-specific genes in K562 cells , 2018, Archives of Toxicology.

[15]  U. Matte,et al.  The role of B7 costimulation in benzene immunotoxicity and its potential association with cancer risk , 2018, Environmental research.

[16]  A. Krężel,et al.  Metal binding properties, stability and reactivity of zinc fingers , 2018, Coordination Chemistry Reviews.

[17]  Y. Hayashi,et al.  Setd2 regulates quiescence and differentiation of adult hematopoietic stem cells by restricting RNA polymerase II elongation , 2018, Haematologica.

[18]  Saijuan Chen,et al.  Setd2 deficiency impairs hematopoietic stem cell self-renewal and causes malignant transformation , 2018, Cell Research.

[19]  J. Mecinović,et al.  Inhibition of histone lysine methyltransferases G9a and GLP by ejection of structural Zn(II). , 2018, Bioorganic & medicinal chemistry letters.

[20]  S. Armstrong,et al.  SETD2 alterations impair DNA damage recognition and lead to resistance to chemotherapy in leukemia. , 2017, Blood.

[21]  I. Davis,et al.  SETting the Stage for Cancer Development: SETD2 and the Consequences of Lost Methylation. , 2017, Cold Spring Harbor Perspectives in Medicine.

[22]  S. Jia,et al.  Molecular basis for the role of oncogenic histone mutations in modulating H3K36 methylation , 2017, Scientific Reports.

[23]  J. Bolton,et al.  Formation and Biological Targets of Quinones: Cytotoxic versus Cytoprotective Effects , 2016, Chemical research in toxicology.

[24]  Andy H. Vo,et al.  Structure/Function Analysis of Recurrent Mutations in SETD2 Protein Reveals a Critical and Conserved Role for a SET Domain Residue in Maintaining Protein Stability and Histone H3 Lys-36 Trimethylation* , 2016, The Journal of Biological Chemistry.

[25]  C. Allis,et al.  Molecular basis for oncohistone H3 recognition by SETD2 methyltransferase , 2016, Genes & development.

[26]  Gerben Duns,et al.  SETD2: an epigenetic modifier with tumor suppressor functionality , 2016, Oncotarget.

[27]  Ivan Rusyn,et al.  Epigenetic alterations induced by genotoxic occupational and environmental human chemical carcinogens: A systematic literature review. , 2016, Mutation research. Reviews in mutation research.

[28]  S. Gangemi,et al.  Benzene exposure is associated with epigenetic changes (Review). , 2016, Molecular medicine reports.

[29]  S. Bohlander,et al.  Disturbing the histone code in leukemia: translocations and mutations affecting histone methyl transferases. , 2015, Cancer genetics.

[30]  Kristina M. Cook,et al.  Inhibition of the HIF1α-p300 interaction by quinone- and indandione-mediated ejection of structural Zn(II). , 2015, European journal of medicinal chemistry.

[31]  A. Jeltsch,et al.  Role of somatic cancer mutations in human protein lysine methyltransferases. , 2014, Biochimica et biophysica acta.

[32]  B. Sonawane,et al.  Lymphohematopoietic cancers induced by chemicals and other agents and their implications for risk evaluation: An overview. , 2014, Mutation research. Reviews in mutation research.

[33]  Heather L. Mulder,et al.  The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes , 2014, Nature Communications.

[34]  S. Armstrong,et al.  Mutations in epigenetic regulators including SETD2 are gained during relapse in pediatric acute lymphoblastic leukemia , 2014, Nature Communications.

[35]  S. Mi,et al.  Identification of functional cooperative mutations of SETD2 in human acute leukemia , 2014, Nature Genetics.

[36]  C. Lim,et al.  Identification of labile Zn sites in drug-target proteins. , 2013, Journal of the American Chemical Society.

[37]  Sharon Y. R. Dent,et al.  The role of chromatin modifiers in normal and malignant hematopoiesis. , 2013, Blood.

[38]  R. H. Simoyi,et al.  Substituent effects on the reactivity of benzoquinone derivatives with thiols. , 2013, Chemical research in toxicology.

[39]  Luoping Zhang,et al.  Current understanding of the mechanism of benzene-induced leukemia in humans: implications for risk assessment. , 2012, Carcinogenesis.

[40]  E. Wagner,et al.  Understanding the language of Lys36 methylation at histone H3 , 2012, Nature Reviews Molecular Cell Biology.

[41]  C. Skibola,et al.  Benzene, the exposome and future investigations of leukemia etiology. , 2011, Chemico-biological interactions.

[42]  S. Quintal,et al.  Zinc finger proteins as templates for metal ion exchange and ligand reactivity. Chemical and biological consequences. , 2011, Metallomics : integrated biometal science.

[43]  N. Rothman,et al.  Human benzene metabolism following occupational and environmental exposures. , 2010, Chemico-biological interactions.

[44]  Martyn T. Smith,et al.  Advances in understanding benzene health effects and susceptibility. , 2010, Annual review of public health.

[45]  L. Mahadevan,et al.  Dynamic histone H3 methylation during gene induction: HYPB/Setd2 mediates all H3K36 trimethylation , 2007, The EMBO journal.

[46]  N. Osheroff,et al.  Quinone-induced enhancement of DNA cleavage by human topoisomerase IIalpha: adduction of cysteine residues 392 and 405. , 2007, Biochemistry.

[47]  Brent A. Johnson,et al.  Modeling Human Metabolism of Benzene Following Occupational and Environmental Exposures , 2006, Cancer Epidemiology Biomarkers & Prevention.

[48]  Brent A. Johnson,et al.  Using urinary biomarkers to elucidate dose-related patterns of human benzene metabolism. , 2006, Carcinogenesis.

[49]  P. Hatcher,et al.  Mechanism of arylating quinone toxicity involving Michael adduct formation and induction of endoplasmic reticulum stress. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[50]  D. Eastmond,et al.  Topoisomerase II inhibition by myeloperoxidase-activated hydroquinone: a potential mechanism underlying the genotoxic and carcinogenic effects of benzene. , 2005, Chemico-biological interactions.

[51]  Robert A Copeland,et al.  Evaluation of enzyme inhibitors in drug discovery. A guide for medicinal chemists and pharmacologists. , 2005, Methods of biochemical analysis.

[52]  N. Osheroff,et al.  1,4-Benzoquinone is a topoisomerase II poison. , 2004, Biochemistry.

[53]  M Vijayaraj Reddy,et al.  Genotoxicity of benzene and its metabolites. , 2004, Mutation research.

[54]  D. Eastmond,et al.  Inhibition of human topoisomerase II in vitro by bioactive benzene metabolites. , 1996, Environmental health perspectives.

[55]  P Grasso,et al.  Leukemia and benzene. , 1983, Annals of internal medicine.